Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Finance

Mining, financial stocks drag FTSE 100 lower; Clinigen Group tumbles

Mining, financial stocks drag FTSE 100 lower; Clinigen Group tumbles

Published : , on

By Devik Jain

(Reuters) – London’s FTSE 100 inex underperformed its European peers on Wednesday, weighed down by heavyweight financials and mining stocks, while Clinigen Group eyed its worst day on record after a downbeat earnings update.

The blue-chip index fell 0.6%, dragged down by life insurers, base metal miners and homebuilders.

Banks gave up 1.3%, with Barclays leading the decline. HSBC Holdings slipped 1.2% after Moody’s downgraded its senior insecured debt rating to A3 from A2.

The domestically focused mid-cap FTSE 250 index declined 0.4%.

World stock prices held near record highs as investors bet the Federal Reserve is some way off from tapering its economic stimulus.

“It has been a very quiet week. Everyone is waiting for the ECB decision and the U.S. inflation numbers tomorrow. Volumes are very light and there’s not much sort of decisive leadership across sectors,” said Ian Williams, economics & strategy research analyst at Peel Hunt.

“Compared to the Fed and even the Bank of England, the ECB probably would be a little bit more cautious and the withdrawal of stimulus in the eurozone is further away than it is here or in the U.S.”

After breaking above the 7,000 mark in mid-April, the FTSE 100 index has oscillated in a narrow range on worries that rapid economic growth could lead to higher inflation and faster tightening of ultra-loose monetary policies.

Among stocks, Smith+Nephew jumped 4% to the top of the FTSE 100 index, after Credit Suisse upgraded the medical products maker’s stock to “outperform” from “neutral”.

Clinigen Group slumped 23% as RBC cut its price target on the stock after the pharmaceutical company forecast annual adjusted EBITDA within the range of 114 million pounds and 117 million pounds, lower than market expectations.

Upper Crust owner SSP Group reversed its course to trade 1.2% higher even after it reported a first-half loss of 182 million pounds ($257.62 million), bringing its shortfall over the past 18 months to more than 600 million pounds.

(Reporting by Devik Jain in Bengaluru; Editing by Subhranshu Sahu)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post